Alban Chesneau

Alban Chesneau has a diverse work experience in various industries. Starting in 2001, they worked as an R&D researcher in Life sciences and bioinformatics at Harvard Medical School-CNRS, where they also served as a scientific consultant and worked on technical studies and feasibility projects for biotech analytical processes. From 2003 to 2008, they were involved in biotech market intelligence and network development for various associations. In 2005, they became a European program project leader at EMBL, focusing on developing innovative bioproduction and analytical methods. In 2008, they joined GAC Group as an R&D and innovation consultant, eventually becoming an operations director and senior manager responsible for technology financing, team management, and consulting department coordination. From 2016 to 2017, they served as the Carbon Waters project transfer manager at Aquitaine Science Transfert, handling marketing, business plan, business development, and technical team management. Since 2018, they have served as the CEO of Carbon Waters.

Alban Chesneau's education history begins with their enrollment at Harvard University, although the specific dates are not provided. There is no information about the degree or field of study obtained during this period. However, in 2001, they began their studies at Harvard Medical School, where they pursued a PhD in Biochemistry. This program lasted until 2003.

After completing their PhD, Alban Chesneau attended the IAE FRANCE - Écoles Universitaires de Management from 2007 to 2009, where they obtained an MBA in Business Administration and Management, General. Finally, in the period between 2003 and 2005, they pursued another PhD, this time at the University of Montpellier, focusing on Biotechnology.

No information is given regarding the start and end dates of their education at Harvard University or any specific fields of study for their programs at Harvard or the University of Montpellier.